Precision will be at this year’s CAR-TCR Summit September 17 – 20, 2024, in Boston, MA. Connect with our team as they lead meaningful presentations and discussions throughout this event providing insights into the manufacturing and commercialization of cell therapies.

Connect with us and schedule in-person or virtual meetings with one of our experts!

• Precision will be facilitating Manufacturing track panel discussion “Blueprints for Success: Building a Cutting-Edge Cell Therapy Facility” on September 18, 2024, 11:10 – 11:40 am ET.
• Precision will have a plenary speaking position “From Innovation to Implementation: Commercializing Cell Therapies” on September 19, 2024, 9:00 – 9:30 am ET.

Panel Discussion in the Manufacturing Track: Blueprints for Success: Building a Cutting-Edge Cell Therapy Facility
Precision | Wednesday, September 18, 2024, 11:10 – 11:40 am ET

• Key Takeaways
  • Hear from industry experts on their approach to building an innovative cell therapy technical operations and manufacturing infrastructure
  • Learn about strategies to establish various workstreams like project controls, CQV, quality and automation
  • Gain key insights into what is needed to reduce cost of manufacturing cell therapies
• Speakers:
  • [Moderator] Jacob Greenwood, VP (Project Farma)
  • Kate Jorgensen, Site Head, Operations (Elevate Bio) 
  • Justin Skoble, Vice President of Technical Operations (Caribou Biosciences)

Plenary Speaking Position: From Innovation to Implementation: Commercializing Cell Therapies
Precision | Thursday, September 19, 2024, 9:00 – 9:30 am ET  

• Key Takeaways
  • The future of the cell therapy industry
  • Strategies to streamline commercialization of cell therapies
  • Overcoming clinical, manufacturing and regulatory hurdles needed for commercialization
  • Evolving your cell therapy organization from a clinical to a commercial mindset
• Speakers:
  • [Moderator] Andy Kinley, VP, Operational Strategy (Precision for Medicine)
  • John Khoury, EVP (Project Farma)
  • Robert Ang, CEO (Vor Bio)
  • John Lunger, Chief Patient Supply Office (Adaptimmune Therapeutics)